Summit Therapeu ADR (SMMT)
18.19 -0.01 (-0.05%) 01/16/25 [NASDAQ]
17.99 x 600 18.29 x 300
Realtime by (Cboe BZX)
17.99 x 600 18.29 x 300
Realtime 18.29 +0.10 (+0.55%) 17:19 ET
for Thu, Jan 16th, 2025
Results
download Want to compare other data? Select FieldsSymbol | SMMT | NBIX | STVN | ||
Company | Summit Therapeu ADR | Neurocrine Bioscienc | Stevanato Group S.P.A. | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NYSE | ||
Open | 18.18 | 142.75 | 21.91 | ||
High | 18.50 | 143.50 | 23.12 | ||
Low | 17.68 | 140.73 | 21.42 | ||
Last | 18.19 | 141.92 | 22.91 | ||
Change | -0.01 | -0.64 | +0.76 | ||
% Change | -0.05% | -0.45% | +3.43% | ||
Volume | 2,136,400 | 776,100 | 301,028 | ||
20-Day Average Volume | 2,389,975 | 1,053,515 | 388,000 | ||
Previous Close | 18.20 | 142.56 | 22.15 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 18.14 | 138.25 | 22.31 | ||
20-Day Raw Stochastic | 55.99% | 80.89% | 65.81% | ||
20-Day Relative Strength | 49.15% | 63.37% | 56.36% | ||
Weighted Alpha | +5.57 | +6.94 | -12.31 | ||
Today's Opinion | 8% Buy | 56% Buy | 88% Buy | ||
Previous Opinion | 8% Buy | 56% Buy | 64% Buy | ||
Last Month's Opinion | 24% Buy | 40% Sell | 24% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -3.35% since 01/08/25 | +2.31% since 01/08/25 | -4.30% since 01/08/25 | ||
Low | 16.46 on 01/14/25 | 137.49 on 01/10/25 | 21.15 on 01/14/25 | ||
High | 18.91 on 01/10/25 | 144.24 on 01/14/25 | 23.89 on 01/10/25 | ||
1-Month | |||||
%Chg | -2.62% since 12/16/24 | +6.67% since 12/16/24 | -1.80% since 12/16/24 | ||
Low | 16.46 on 01/14/25 | 132.10 on 12/17/24 | 20.08 on 12/23/24 | ||
High | 19.55 on 12/26/24 | 144.24 on 01/14/25 | 24.38 on 01/06/25 | ||
3-Month | |||||
%Chg | -22.46% since 10/16/24 | +19.92% since 10/16/24 | +24.85% since 10/16/24 | ||
Low | 16.46 on 01/14/25 | 113.88 on 10/25/24 | 17.12 on 10/25/24 | ||
High | 23.78 on 10/17/24 | 144.24 on 01/14/25 | 24.90 on 12/13/24 | ||
6-Month | |||||
%Chg | +99.45% since 07/16/24 | -3.75% since 07/16/24 | +4.04% since 07/16/24 | ||
Low | 8.71 on 07/19/24 | 110.95 on 10/03/24 | 17.12 on 10/25/24 | ||
High | 33.89 on 09/16/24 | 157.98 on 08/01/24 | 24.90 on 12/13/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 13,421,554 | 14,433,772 | 6,546,211 | ||
Shares Outstanding, K | 737,448 | 101,247 | 295,540 | ||
Annual Sales | 0 | 1,887,100,000 | 1,174,680,000 | ||
Annual Net Income | -614,930,000 | 249,700,000 | 157,620,000 | ||
Last Quarter Sales | 0 | 622,100,000 | 305,540,000 | ||
Last Quarter Net Income | -56,250,000 | 129,800,000 | 33,010,000 | ||
60-Month Beta | -0.87 | 0.33 | 0.56 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.08 on 10/30/24 | 1.24 on 10/30/24 | 0.13 on 11/05/24 | ||
Latest Earnings Date | 02/18/25 | 02/05/25 | 03/06/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 37.40 | 42.45 |